" Momentum is skyrocketing for biogenerics legislation that puts patients and pharmaceutical innovation first . The legislation introduced today in the Senate and last week in the House demonstrates that life-saving biogenerics can get to patients in need sooner rather than later while also fostering competition to drive pharmaceutical innovation . We applaud Senators Chuck Schumer ( D-NY ) , Sherrod Brown ( D-OH ) , Susan Collins ( R-ME ) , Mel Martinez ( R-FL ) , Jeanne Shaheen ( D-NH ) , Debbie Stabenow ( D-MI ) and David Vitter ( R-LA ) for their commitment to increasing access to these life-saving medicines while also ultimately reducing overall health care costs .